JP2010029659A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010029659A5 JP2010029659A5 JP2009172410A JP2009172410A JP2010029659A5 JP 2010029659 A5 JP2010029659 A5 JP 2010029659A5 JP 2009172410 A JP2009172410 A JP 2009172410A JP 2009172410 A JP2009172410 A JP 2009172410A JP 2010029659 A5 JP2010029659 A5 JP 2010029659A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- risk characteristic
- characteristic value
- prostate
- risk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 75
- 210000002307 prostate Anatomy 0.000 claims description 38
- 208000017497 prostate disease Diseases 0.000 claims description 34
- 238000012360 testing method Methods 0.000 claims description 21
- 238000003745 diagnosis Methods 0.000 claims description 18
- 238000012216 screening Methods 0.000 claims description 18
- 210000001519 tissue Anatomy 0.000 claims description 15
- 238000004458 analytical method Methods 0.000 claims description 14
- 238000003384 imaging method Methods 0.000 claims description 8
- 238000011156 evaluation Methods 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 2
- 230000008520 organization Effects 0.000 claims description 2
- 238000001574 biopsy Methods 0.000 description 16
- 238000007726 management method Methods 0.000 description 12
- 238000002604 ultrasonography Methods 0.000 description 11
- 230000008569 process Effects 0.000 description 10
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 8
- 102100038358 Prostate-specific antigen Human genes 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010060862 Prostate cancer Diseases 0.000 description 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 3
- 238000002607 contrast-enhanced ultrasound Methods 0.000 description 3
- 238000013480 data collection Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 2
- 238000007418 data mining Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
Images
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008034703 | 2008-07-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010029659A JP2010029659A (ja) | 2010-02-12 |
| JP2010029659A5 true JP2010029659A5 (OSRAM) | 2012-06-21 |
Family
ID=41128041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009172410A Pending JP2010029659A (ja) | 2008-07-25 | 2009-07-23 | 患者の前立腺に関係するパラメータを求める方法および装置 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100022912A1 (OSRAM) |
| EP (1) | EP2147637A1 (OSRAM) |
| JP (1) | JP2010029659A (OSRAM) |
| CN (1) | CN101632604A (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2782058A1 (en) * | 2013-03-20 | 2014-09-24 | Valuetainment AG | Information system to obtain an exposition rating of a geographical area |
| US10682098B2 (en) * | 2018-03-22 | 2020-06-16 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Predictive use of quantitative imaging |
| CN115472282A (zh) * | 2021-06-11 | 2022-12-13 | 中国科学院理化技术研究所 | 一种前列腺癌早期诊断系统 |
| US20250061983A1 (en) * | 2023-08-19 | 2025-02-20 | Pathology Watch Inc. | Systems, methods, and devices for a cancer pathology laboratory information system (lis) |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726664D0 (en) * | 1997-12-17 | 1998-02-18 | Nycomed Imaging As | Improvements in or relating to ultrasonography |
| DE69937564T2 (de) * | 1998-08-03 | 2008-10-23 | Ronald E. Sarasota Wheeler | Prostata- formulierung |
| US20030100828A1 (en) * | 2001-11-29 | 2003-05-29 | Siemens Aktiengesellschaft | Method for minimally invasive prostate tumor treatment |
| US6824516B2 (en) * | 2002-03-11 | 2004-11-30 | Medsci Technologies, Inc. | System for examining, mapping, diagnosing, and treating diseases of the prostate |
| US20040092807A1 (en) * | 2002-11-07 | 2004-05-13 | Amos Breskin | System and method for cancer detection |
| JP4169686B2 (ja) * | 2003-01-15 | 2008-10-22 | 株式会社マリネックス | 健康診断システム、検査方法および健康診断車両 |
| DE10303717A1 (de) * | 2003-01-30 | 2005-07-07 | Siemens Ag | Patientenmonitor mit integrierten Ultraschallmodulen |
| JP2004303067A (ja) * | 2003-03-31 | 2004-10-28 | Mochida Pharmaceut Co Ltd | 検査結果管理システム |
| US20040254445A1 (en) * | 2003-06-13 | 2004-12-16 | Craig Bittner | Use of MRI to screen individuals for prostate cancer |
| JP2007524461A (ja) * | 2003-06-25 | 2007-08-30 | シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド | 乳房撮像の自動診断及び決定支援システム及び方法 |
| US7467119B2 (en) * | 2003-07-21 | 2008-12-16 | Aureon Laboratories, Inc. | Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition |
| JP2005165886A (ja) * | 2003-12-05 | 2005-06-23 | Srl Inc | 検査情報分析システム |
| WO2007011372A2 (en) * | 2004-09-09 | 2007-01-25 | The Regents Of The University Of California | Therapeutic and prognostic factor yy1 in human cancer |
| WO2006054635A1 (ja) * | 2004-11-17 | 2006-05-26 | Hitachi Medical Corporation | 超音波診断装置及び超音波画像表示方法 |
| JP4795681B2 (ja) * | 2004-12-27 | 2011-10-19 | 富士フイルム株式会社 | 診断支援装置、診断支援方法およびそのプログラム |
| WO2006089426A1 (en) * | 2005-02-28 | 2006-08-31 | Robarts Research Institute | System and method for performing a biopsy of a target volume and a computing device for planning the same |
| CN101150990B (zh) * | 2005-03-30 | 2010-12-01 | 株式会社日立医药 | 超声波诊断装置 |
| JP2006302222A (ja) * | 2005-04-15 | 2006-11-02 | Toshihiro Handa | 癌発症リスク予測システム及び方法、並びに癌デリバティブ方法 |
| JP2007280229A (ja) * | 2006-04-11 | 2007-10-25 | Fujifilm Corp | 類似症例検索装置、類似症例検索方法およびそのプログラム |
| US8425418B2 (en) * | 2006-05-18 | 2013-04-23 | Eigen, Llc | Method of ultrasonic imaging and biopsy of the prostate |
| US20090075284A1 (en) * | 2006-09-19 | 2009-03-19 | The Regents Of The University Of Michigan | Metabolomic profiling of prostate cancer |
| US20080102451A1 (en) * | 2006-10-31 | 2008-05-01 | Abbott Laboratories | Companion diagnostic assays for endothelin receptor antagonists |
| DE102007026910A1 (de) | 2007-06-12 | 2008-12-18 | Siemens Ag | Untersuchungseinheit mit integrierter Minilabor-Analyseeinheit |
-
2009
- 2009-06-23 EP EP09163494A patent/EP2147637A1/de not_active Withdrawn
- 2009-07-23 JP JP2009172410A patent/JP2010029659A/ja active Pending
- 2009-07-24 US US12/508,723 patent/US20100022912A1/en not_active Abandoned
- 2009-07-27 CN CN200910164694A patent/CN101632604A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4354685B2 (ja) | 医学的に重要なデータの処理装置およびシステム | |
| CN102959579B (zh) | 医疗信息显示装置、操作方法及程序 | |
| CN100366211C (zh) | 诊断信息系统 | |
| JP2007524461A (ja) | 乳房撮像の自動診断及び決定支援システム及び方法 | |
| CN106232047A (zh) | 用于健康成像信息学的系统和方法 | |
| EP4162505A1 (en) | System and methods for enhanced automated endoscopy procedure workflow | |
| Massey et al. | Clinical validation and extension of an automated, deep learning–based algorithm for quantitative sinus CT analysis | |
| CN111968742A (zh) | 一种肺癌基因突变的跨模态预测系统及方法 | |
| Hu et al. | Association of early adulthood 25-year blood pressure trajectories with cerebral lesions and brain structure in midlife | |
| JP2010029659A5 (OSRAM) | ||
| JP2010029659A (ja) | 患者の前立腺に関係するパラメータを求める方法および装置 | |
| CN117011892A (zh) | 一种基于深度学习的超声图像自动分析与诊断系统 | |
| US20250107724A1 (en) | Systems and methods for validating magnetic resonance imaging (mri) machines and mri data | |
| Albert et al. | Short Version of the Guideline: Early Detection of Breast Cancer in Germany: An evidence-, consensus-, and outcome-based guideline according to the German Association of the Scientific Medical Societies (AWMF) and the German Agency for Quality in Medicine (AeZQ) | |
| Mali | Surveillance of head neck cancer: Case for personalized and standardized surveillance | |
| JP2012149994A (ja) | 医用データ処理装置、医用データ処理プログラム及び核医学診断装置 | |
| RU2742429C1 (ru) | Способ экспресс-оценки изменений легочной ткани при COVID-19 без применения компьютерной томографии органов грудной клетки | |
| JP2003132143A (ja) | 臨床検査システム | |
| JP2001273363A (ja) | 高度健診支援方法及びその実施装置並びにその処理プログラムを記録した記録媒体 | |
| Horsch et al. | How to identify and assess tasks and challenges of medical image processing | |
| Hackethal et al. | A structured questionnaire improves preoperative assessment of endometriosis patients: a retrospective analysis and prospective trial | |
| CN119856942A (zh) | 一种体外检测食管癌的系统 | |
| Weigel et al. | Normative connectome-based analysis of sensorimotor deficits in acute subcortical stroke | |
| Scotland | Colorectal cancer–clinical quality performance indicators | |
| Aas-Eng | O-096 Imaging for endometriosis: from the past to the future |